Mai L, WuY, Luo J, et al. - Through a retrospective cohort study carried out in the Shunde Hospital, Southern Medical University and the second hospital of Zhaoqing, China, from January 2013 to December 31, 2018, of 3,612 patients aged ≥ 18 years who were hospitalized for acute coronary syndrome (ACS) and received percutaneous coronary intervention (PCI) treatment, experts analyzed prevailing real-world patterns of oral anticoagulants (OACs) therapy in managing patients with ACS and atrial fibrillation (AF) in Southern China who underwent PCI. Approximately 8% of individuals who underwent PCI during ACS hospitalization had AF. However these patients were at a heightened risk of stroke, anticoagulant therapy was considerably underused. Individuals with paroxysmal AF and an enhanced risk of bleeding were less inclined to get anticoagulant treatment. Nevertheless, the promotion of non-vitamin K antagonist OACs use could enhance the treatment of anticoagulation in these patients.